|
TAF11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.644300E-04 |
| Normal-vs-Stage3 |
1.11022302462516E-15 |
| Normal-vs-Stage4 |
1.64301905414277E-12 |
| Stage1-vs-Stage2 |
3.976000E-02 |
| Stage1-vs-Stage3 |
1.249970E-01 |
| Stage1-vs-Stage4 |
4.664200E-03 |
| Stage2-vs-Stage3 |
5.623400E-03 |
| Stage2-vs-Stage4 |
8.444500E-04 |
| Stage3-vs-Stage4 |
3.240600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.53970000082992E-08 |
| Normal-vs-Asian |
1.72780012519524E-10 |
| Caucasian-vs-AfricanAmerican |
9.742400E-01 |
| Caucasian-vs-Asian |
2.088600E-01 |
| AfricanAmerican-vs-Asian |
4.602800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.47437617670221E-13 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
6.621000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.77990955307905E-12 |
| Normal-vs-Age(81-100Yrs) |
4.289200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.306200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.698800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.873000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.596200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.304800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.609400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.53780999999631E-05 |
| Classical-VS-Follicular |
4.62420000002517E-06 |
| Classical-VS-Other |
8.164000E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
6.71880329150554E-11 |
| Tall-VS-Other |
5.031600E-02 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
1.295240E-01 |
| Follicular-VS-Normal |
1.93262000000027E-05 |
| Other-VS-Normal |
2.42079999999145E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.65534252971611E-13 |
| Normal-vs-N1 |
6.20614670765463E-14 |
| N0-vs-N1 |
6.601000E-03 |
|
|
